Clinical significance of expression of tumor immunogenic cell death related molecules
10.3760/cma.j.cn371439-20210607-00017
- VernacularTitle:肿瘤免疫原性细胞死亡相关分子表达的临床意义
- Author:
Lu XU
1
;
Jinhua LONG
;
Feng JIN
;
Weili WU
Author Information
1. 贵州医科大学临床医学院,贵阳 550000
- Keywords:
Calreticulin;
HSC70 heat-shock proteins;
HMGB1 protein;
Immunogenic cell death
- From:
Journal of International Oncology
2022;49(2):106-110
- CountryChina
- Language:Chinese
-
Abstract:
Tumor immunogenic cell death is a type of regulatory cell death, which is driven by stress including chemotherapy drugs, radiotherapy, oncolytic virus, nano carrier drugs and photodynamic force. It can induce specific immune response to tumor death cell antigen. The further study can provide theoretical basis and new ideas for anti-tumor immunity and clinical immunotherapy of tumor.